Cardioprotection against ischaemia/reperfusion by vitamins C and E plus n-3 fatty acids: Molecular mechanisms and potential clinic applications

Clinical Science

Volumn 124, Issue 1, 2013, Pages 1-15

  Rodrigo, Ramón ^a   Prieto, Juan C ^a,b   Castillo, Rodrigo ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Antioxidant; Apoptosis; Autophagy; Ischaemia reperfusion; Necrosis; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; C REACTIVE PROTEIN; CATECHOLAMINE; CXCL2 CHEMOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIPOXYGENASE; MYELOPEROXIDASE; OMEGA 3 FATTY ACID; PROTEIN BAX; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SUPEROXIDE; TRANSCRIPTION FACTOR NRF2; XANTHINE OXIDASE; CARDIOTONIC AGENT;

APOPTOSIS; AUTOPHAGY; CELL COMMUNICATION; CELL DEATH; DISEASE DURATION; ELECTRON TRANSPORT; ENDOTHELIUM CELL; ENZYME ACTIVITY; HEART MUSCLE CELL; HEART PROTECTION; INFLAMMATION; MITOCHONDRIAL RESPIRATION; MOLECULAR INTERACTION; MOLECULAR MECHANICS; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; UPREGULATION; BIOLOGICAL MODEL; BLOOD; DRUG EFFECT; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

APOPTOSIS; ASCORBIC ACID; CARDIOTONIC AGENTS; FATTY ACIDS, OMEGA-3; HUMANS; MODELS, BIOLOGICAL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; VITAMIN E;

EID: 84871700971     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20110663     Document Type: Review

References (131)

1. Roe, M. T., Halabi, A. R., Mehta, R. H., Chen, A. Y., Newby, L. K., Harrington, R. A., Smith, Jr, S. C., Ohman, E. M., Gibler, W. B. and Peterson, E. D. (2007) Documented traditional cardiovascular risk factors and mortality in non-ST-segment elevation myocardial infarction. Am. Heart J. 153, 507-514
2. Rodrigo, R. (2009) Oxidative Stress and Antioxidants: Their Role in Human Disease, Nova Science Publishers, New York
3. Vanden Hoek, T. L., Li, C., Shao, Z., Schumacker, P. T. and Becker, L. B. (1997) Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J. Mol. Cell. Cardiol. 29, 2571-2583
4. Mallat, Z., Philip, I., Lebret, M., Chatel, D., Maclouf, J. and Tedgui, A. (1998) Elevated levels of 8-iso-prostaglandin F2α in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97, 1536-1539
5. Misra, M. K., Sarwat, M., Bhakuni, P., Tuteja, R. and Tuteja, N. (2009) Oxidative stress and ischemic myocardial syndromes. Med. Sci. Monit. 15, RA209-RA219
6. Brown, D. I. and Griendling, K. K. (2009) Nox proteins in signal transduction. Free Radical Biol. Med. 47, 1239-1253
7. Ushio-Fukai, M. (2009) Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid. Redox Signaling 11, 1289-1299
8. Jones, W. K., Brown, M., Ren, X., He, S. and McGuinness, M. (2003) NF-κB as an integrator of diverse signaling pathways: the heart of myocardial signaling? Cardiovasc. Toxicol. 3, 229-254
9. Nakamura, T., Goto, M., Matsumoto, A. and Tanaka, I. (1998) Inhibition of NF-κB transcriptional activity by α-tocopheryl succinate. Biofactors. 7, 21-30
10. Kaileh, M. and Sen, R. (2010) Role of NF-κB in the anti-inflammatory effects of tocotrienols. J. Am. Coll. Nutr. 29 (Suppl. 3), 334S-339S
11. Wang, Y. Y., Liu, S., Lian, F., Yang, W. G. and Xue, S. (2011) Toll-like receptor 7/8 agonist resiquimod induces late preconditioning in neonatal cardiac myocytes. Acta Pharmacol. Sin. 32, 565-572
12. Niu, J., Wang, K., Graham, S., Azfer, A. and Kolattukudy, P. E. (2011) MCP-1-induced protein attenuates endotoxin-induced myocardial dysfunction by suppressing cardiac NF-κB activation via inhibition of IκB kinase activation. J. Mol. Cell. Cardiol. 51, 177-186
13. Gasparetto, C., Malinverno, A., Gulacciati, D., Gritti, D., Prosperini, P. G., Specchia, G. and Ricevuti, G. (2005) Antioxidant vitamins reduce oxidative stress and ventricular remodeling in patients with acute myocardial infarction. Int. J. Immunopathol. Pharmacol. 18, 487-496
14. Chen, Z., Siu, B., Ho, Y. S., Vincent, R., Chua, C. C., Hamdy, R. C. and Chua, B. H. (1998) Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J. Mol. Cell. Cardiol. 30, 2281-2289
15. Kobayashi, M. and Yamamoto, M. (2005) Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid. Redox Signaling 7, 385-394
16. Zhu, H., Jia, Z., Misra, B. R., Zhang, L., Cao, Z., Yamamoto, M., Trush, M. A., Misra, H. P. and Li, Y. (2008) Nuclear factor E2-related factor 2-dependent myocardiac cytoprotection against oxidative and electrophilic stress. Cardiovasc. Toxicol. 8, 71-85
17. Yellon, D. M. and Hausenloy, D. J. (2007) Myocardial reperfusion injury. N. Engl. J. Med. 357, 1121-1135
18. Liu, C., Xie, G., Huang, W., Yang, Y., Li, P. and Tu, Z. (2012) Elevated serum myeloperoxidase activities are significantly associated with the prevalence of ACS and high LDL-C levels in CHD patients. J. Atheroscler. Thromb. 19, 435-443
19. Shin, I. W., Jang, I. S., Lee, S. M., Park, K. E., Ok, S. H., Sohn, J. T., Lee, H. K. and Chung, Y. K. (2011) Myocardial protective effect by ulinastatin via an anti-inflammatory response after regional ischemia/reperfusion injury in an in vivo rat heart model. Korean J. Anesthesiol. 61, 499-505
20. Li, T. T., Zhang, Y. S., He, L., Li, N. S., Peng, J. and Li, Y. J. (2011) Protective effect of phloroglucinol against myocardial ischaemia/reperfusion injury is related to inhibition of myeloperoxidase activity and inflammatory cell infiltration. Clin. Exp. Pharmacol. Physiol. 38, 27-33
21. Vandervelde, S., van Luyn, M. J., Rozenbaum, M. H., Petersen, A. H., Tio, R. A. and Harmsen, M. C. (2007) Stem cell-related cardiac gene expression early after murine myocardial infarction. Cardiovasc. Res. 73, 783-793
22. Chandrasekar, B., Smith, J. B. and Freeman, G. L. (2001) Ischaemia/reperfusion of rat myocardium activates nuclear factor-κB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation 103, 2296-2302
23. Kinoshita, T., Asai, T., Takashima, N., Hosoba, S., Suzuki, T., Kambara, A. and Matsubayashi, K. (2011) Preoperative C-reactive protein and atrial fibrillation after off-pump coronary bypass surgery. Eur. J. Cardiothorac. Surg. 40, 1298-1303
24. Valtchanova-Matchouganska, A., Gondwe, M. and Nadar, A. (2004) The role of C-reactive protein in ischaemia/reperfusion injury and preconditioning in a rat model of myocardial infarction. Life Sci. 75, 901-910
25. Gale, C. P., Metcalfe, E., West, R. M., Das, R., Kilcullen, N., Morrell, C., Crook, R., Batin, P. D., Hall, A. S. and Barth, J. H. (2011) An assessment of the concentration-related prognostic value of cardiac troponin I following acute coronary syndrome. Am. J. Cardiol. 108, 1259-1265
26. Whelan, R. S., Kaplinskiy, V. and Kitsis, R. N. (2010) Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu. Rev. Physiol. 72, 19-44
27. Lee, P., Sata, M., Lefer, D. J., Factor, S. M., Walsh, K. and Kitsis, R. N. (2003) Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. Am. J. Physiol. Heart Circ. Physiol. 284, H456-H463
28. Dallabrida, S. M., Ismail, N., Oberle, J. R., Himes, B. E. and Rupnick, M. A. (2005) Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins. Circ. Res. 96, e8-e24
29. Cande, C., Cohen, I., Daugas, E., Ravagnan, L., Larochette, N., Zamzami, N. and Kroemer, G. (2002) Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria. Biochimie 84, 215-222
30. Communal, C., Sumandea, M., de Tombe, P., Narula, J., Solaro, R. J. and Hajjar, R. J. (2002) Functional consequences of caspase activation in cardiac myocytes. Proc. Natl. Acad. Sci. U.S.A. 99, 6252-6256
31. Petros, A. M., Olejniczak, E. T. and Fesik, S. W. (2004) Structural biology of the Bcl-2 family of proteins. Biochim. Biophys. Acta 1644, 83-94
32. Antignani, A. and Youle, R. J. (2006) How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane? Curr. Opin. Cell. Biol. 18, 685-689
33. Youle, R. J. and Strasser, A. (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell. Biol. 9, 47-59
34. Kroemer, G., Galluzzi, L. and Brenner, C. (2007) Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87, 99-163
35. Tsujimoto, Y. and Shimizu, S. (2007) Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 12, 835-840
36. Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., Dorn, G. W. et al. (2005) Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658-662
37. Nakamura, T., Wang, L., Wong, C. C., Scott, F. L., Eckelman, B. P., Han, X., Tzitzilonis, C., Meng, F., Gu, Z., Holland, E. A. et al. (2010) Transnitrosylation of XIAP regulates caspase-dependent neuronal cell death. Mol. Cell. 39, 184-195
38. Tatsumi, T., Shiraishi, J., Keira, N., Akashi, K., Mano, A., Yamanaka, S., Matoba, S., Fushiki, S., Fliss, H. and Nakagawa, M. (2003) Intracellular ATP is required for mitochondrial apoptotic pathways in isolated hypoxic rat cardiac myocytes. Cardiovasc. Res. 59, 428-440
39. Dai, D. F. and Rabinovitch, P. (2011) Mitochondrial oxidative stress mediates induction of autophagy and hypertrophy in angiotensin-II treated mouse hearts. Autophagy 7, 917-918
40. Hariharan, N., Zhai, P. and Sadoshima, J. (2011) Oxidative stress stimulates autophagic flux during ischemia/reperfusion. Antioxid. Redox Signaling 14, 2179-2190
41. Essick, E. E. and Sam, F. (2010) Oxidative stress and autophagy in cardiac disease, neurological disorders, aging and cancer. Oxid. Med. Cell. Longev. 3, 168-177
42. Matsui, Y., Kyoi, S., Takagi, H., Hsu, C. P., Hariharan, N., Ago, T., Vatner, S. F. and Sadoshima, J. (2008) Molecular mechanisms and physiological significance of autophagy during myocardial ischemia and reperfusion. Autophagy 4, 409-415
43. Juhaszova, M., Zorov, D. B., Kim, S. H., Pepe, S., Fu, Q., Fishbein, K. W., Ziman, B. D., Wang, S., Ytrehus, K., Antos, C. L. et al. (2004) Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest. 113, 1535-1549
44. Zhu, H., Tannous, P., Johnstone, J. L., Kong, Y., Shelton, J. M., Richardson, J. A., Le, V., Levine, B., Rothermel, B. A. and Hill, J. A. (2007) Cardiac autophagy is a maladaptive response to hemodynamic stress. J. Clin. Invest. 117, 1782-1793
45. Yan, L., Sadoshima, J., Vatner, D. E. and Vatner, S. F. (2009) Autophagy in ischemic preconditioning and hibernating myocardium. Autophagy 5, 709-712
46. Zhou, L., Azfer, A., Niu, J., Graham, S., Choudhury, M., Adamski, F. M., Younce, C., Binkley, P. F. and Kolattukudy, P. E. (2006) Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction. Circ. Res. 98, 1177-1185
47. Younce, C. W. and Kolattukudy, P. E. (2010) MCP-1 causes cardiomyoblast death via autophagy resulting from ER stress caused by oxidative stress generated by inducing a novel zinc-finger protein, MCPIP. Biochem. J. 426, 43-53
48. Inserte, J., Barrabés, J. A., Hernando, V. and Garcia-Dorado, D. (2009) Orphan targets for reperfusion injury. Cardiovasc. Res. 83, 169-178
49. Watanabe, K., Yaoita, H., Ogawa, K., Oikawa, M., Maehara, K. and Maruyama, Y. (2006) Attenuated cardioprotection by ischemic preconditioning in coronary stenosed heart and its restoration by carvedilol. Cardiovasc. Res. 71, 537-547
50. Ferdinandy, P., Schulz, R. and Baxter, G. F. (2007) Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol. Rev. 59, 418-458
51. Kajstura, J., Cheng, W., Sarangarajan, R., Li, P., Li, B., Nitahara, J. A., Chapnick, S., Reiss, K., Olivetti, G. and Anversa, P. (1996) Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am. J. Physiol. 271, H1215-H1228
52. Ramlawi, B., Feng, J., Mieno, S., Szabo, C., Zsengeller, Z., Clements, R., Sodha, N., Boodhwani, M., Bianchi, C. and Sellke, F. W. (2006) Indices of apoptosis activation after blood cardioplegia and cardiopulmonary bypass. Circulation 114, I257-I263
53. Halestrap, A. P., Clarke, S. J. and Javadov, S. A. (2004) Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc. Res. 61, 372-385
54. Becker, L. B. (2004) New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res. 61, 461-470
55. Murry, C. E., Jennings, R. B. and Reimer, K. A. (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136
56. Matsubara, T., Minatoguchi, S., Matsuo, H., Hayakawa, K., Segawa, T., Matsuno, Y., Watanabe, S., Arai, M., Uno, Y., Kawasaki, M. et al. (2000) Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease. J. Am. Coll. Cardiol. 35, 345-351
57. Sandhu, R., Diaz, R. J., Mao, G. D. and Wilson, G. J. (1997) Ischemic preconditioning: differences in protection and susceptibility to blockade with single-cycle versus multicycle transient ischemia. Circulation 96, 984-995
58. Morihira, M., Hasebe, N., Baljinnyam, E., Sumitomo, K., Matsusaka, T., Izawa, K., Fujino, T., Fukuzawa, J. and Kikuchi, K. (2006) Ischemic preconditioning enhances scavenging activity of reactive oxygen species and diminishes transmural difference of infarct size. Am. J. Physiol. Heart Circ. Physiol. 290, H577-H583
59. Dangas, G. D., Caixeta, A., Mehran, R., Parise, H., Lansky, A. J., Cristea, E., Brodie, B. R., Witzenbichler, B., Guagliumi, G., Peruga, J. Z. et al. (2011) Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation 123, 1745-1756
60. Bagatini, M. D., Martins, C. C., Battisti, V., Gasparetto, D., da Rosa, C. S., Spanevello, R. M., Ahmed, M., Schmatz, R., Schetinger, M. R. and Morsch, V. M. (2011) Oxidative stress versus antioxidant defenses in patients with acute myocardial infarction. Heart Vessels 26, 55-63
61. Takimoto, Y., Aoyama, T., Keyamura, R., Shinoda, E., Hattori, R., Yui, Y. and Sasayama, S. (2000) Differential expression of three types of nitric oxide synthase in both infarcted and non-infarcted left ventricles after myocardial infarction in the rat. Int. J. Cardiol. 76, 135-145
62. Duilio, C., Ambrosio, G., Kuppusamy, P., DiPaula, A., Becker, L. C. and Zweier, J. L. (2001) Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. Am. J. Physiol. Heart Circ. Physiol. 280, H2649-H2657
63. Fukui, T., Yoshiyama, M., Hanatani, A., Omura, T., Yoshikawa, J. and Abe, Y. (2001) Expression of p22-phox and gp91-phox, essential components of NADPH oxidase, increases after myocardial infarction. Biochem. Biophys. Res. Commun. 281, 1200-1206
64. Bhakuni, P., Chandra, M. and Misra, M. K. (2006) Effect of ascorbic acid supplementation on certain oxidative stress parameters in the post reperfusion patients of myocardial infarction. Mol. Cell. Biochem. 290, 153-158
65. Boersma, E. (2006) Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur. Heart J. 27, 779-788
66. Berg, K., Jynge, P., Bjerve, K., Skarra, S., Basu, S. and Wiseth, R. (2005) Oxidative stress and inflammatory response during and following coronary interventions for acute myocardial infarction. Free Radical Res. 39, 629-636
67. Berg, K., Wiseth, R., Bjerve, K., Brurok, H., Gunnes, S., Skarra, S., Jynge, P. and Basu, S. (2004) Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release. Free Radical Res. 38, 517-525
68. 2-isoprostane formation: evidence for in vivo oxidative stress during PTCA. J. Am. Coll. Cardiol. 37, 76-80
69. 2α in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation 96, 3314-3320
70. Vásquez-Vivar, J., Kalyanaraman, B., Martásek, P., Hogg, N., Masters, B. S., Karoui, H, Tordo, P. and Pritchard, Jr, K. A. (1998) Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc. Natl. Acad. Sci. U.S.A. 95, 9220-9225
71. Chalupsky, K. and Cai, H. (2005) Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 102, 9056-9061
72. Nikolic-Heitzler, V., Rabuzin, F., Tatzber, F., Vrkic, N., Bulj, N., Borovic, S., Wonisch, W., Sunko, B. M. and Zarkovic, N. (2006) Persistent oxidative stress after myocardial infarction treated by percutaneous coronary intervention. Tohoku J. Exp. Med. 210, 247-255
73. Akila, V., D'souza, B., Vishwanath, P. and D'souza, V. (2007) Oxidative injury and antioxidants in coronary artery bypass graft surgery: off-pump CABG significantly reduces oxidative stress. Clin. Chim. Acta 375, 147-152
74. Senthil, S., Veerappan, R. M., Ramakrishna, R. M., Rao, M. and Pugalendi, K. V. (2004) Oxidative stress and antioxidants in patients with cardiogenic shock complicating acute myocardial infarction. Clin. Chim. Acta 348, 131-137
75. Pandey, N. R. (2000) Enzymatic oxidant and antioxidants of human blood platelets in unstable angina and myocardial infarction. Int. J. Cardiol. 76, 33-38
76. Bhakuni, P., Chandra, M. and Misra, M. K. (2006) Effect of ascorbic acid supplementation on certain oxidative stress parameters in the post reperfusion patients of myocardial infarction. Mol. Cell. Biochem. 290, 153-158
77. Maisel, W. H., Rawn, J. D. and Stevenson, W. G. (2001) Atrial fibrillation after cardiac surgery. Ann. Intern. Med. 135, 1061-1073
78. Van Wagoner, D. R. (2008) Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. J. Cardiovasc. Pharmacol. 52, 306-313
79. Stephens, N. G., Parsons, A., Schofield, P. M., Kelly, F., Cheeseman, K. and Mitchinson, M. J. (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347, 781-786
80. Rapola, J. M., Virtamo, J., Ripatti, S., Huttunen, J. K., Albanes, D., Taylor, P. R. and Heinonen, O. P. (1997) Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 349, 1715-1720
81. GISSI-Prevenzione trial (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354, 447-455
82. Yusuf, S., Dagenais, G., Pogue, J., Bosch, J. and Sleight, P. (2000) Vitamin E supplementation and cardiovascular events in high-risk patients. N. Engl. J. Med. 342, 154-160
83. de Gaetano, G (2001) Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 357, 89-95
84. Heart Protection Study Collaborative Group (2000) MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360, 23-33
85. Cook, N. R., Albert, C. M., Gaziano, J. M., Zaharris, E., MacFadyen, J., Danielson, E., Buring, J. E. and Manson, J. E. (2007) A Randomized factorial trial of vitamins C, E, and β-carotene in the secondary prevention of cardiovascular events in women: Results from the Women's Antioxidant Cardiovascular Study (WACS). Arch. Intern. Med. 167, 1610-1618
86. Sesso, H. D., Buring, J. E., Christen, W. G., Kurth, T., Belanger, C., MacFadyen, J., Bubes, V., Manson, J. E., Glynn, R. J. and Gaziano, J. M. (2008) Vitamins E and C in the prevention of cardiovascular disease in men: The Physicians' Health Study II Randomized Trial. JAMA, J. Am. Med. Assoc. 300, 2123-2133
87. Guan, W., Osanai, T., Kamada, T., Hanada, H., Ishizaka, H., Onodera, H., Iwasa, A., Fujita, N., Kudo, S., Ohkubo, T. and Okumura, K. (2003) Effect of allopurinol pretreatment on free radical generation after primary coronary angioplasty for acute myocardial infarction. J. Cardiovasc. Pharmacol. 41, 699-705
88. Tsujita, K., Shimomura, H., Kaikita, K., Kawano, H., Hokamaki, J., Nagayoshi, Y., Yamashita, T., Fukuda, M., Nakamura, Y., Sakamoto, T. et al. (2006) Long-term efficacy of edaravone in patients with acute myocardial infarction. Circ. J. 70, 832-837
89. Flaherty, J. T., Pitt, B., Gruber, J. W., Heuser, R. R., Rothbaum, D. A., Burwell, L. R. and George, B. S., Kereiakes, D. J., Deitchman, D., Gustafson, N., et al. (1994) Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation 89, 1982-1991
90. Rodrigo, R., Guichard, C. and Charles, R. (2007) Clinical pharmacology and therapeutic use of antioxidant vitamins. Fundam. Clin. Pharmacol. 21, 111-127
91. Guan, W., Osanai, T., Kamada, T., Ishizaka, H., Hanada, H. and Okumura, K. (1999) Time course of free radical production after primary coronary angioplasty for acute myocardial infarction and the effect of vitamin C. Jpn. Circ. J. 63, 924-928
92. Jaxa-Chamiec, T., Bednarz, B., Drozdowska, D., Gessek, J., Gniot, J., Janik, K., Kawka-Urbanek, T., Maciejewski, P., Ogórek, M. and Szpajer, M. (2005) Antioxidant effects of combined vitamins C and E in acute myocardial infarction. The randomized, double-blind, placebo controlled, multicenter pilot Myocardial Infarction and VITamins (MIVIT) trial. Kardiol. Pol. 62, 344-350
93. Jaxa-Chamiec, T., Bednarz, B., Herbaczynska-Cedro, K., Maciejewski, P. and Ceremuzynski, L. (2009) Effects of vitamins C and E on the outcome after acute myocardial infarction in diabetics: a retrospective, hypothesis-generating analysis from the MIVIT study. Cardiology. 112, 219-223
94. Schneider, M. P., Delles, C., Schmidt, B. M., Oehmer, S., Schwarz, T. K., Schmieder, R. E. and John, S. (2005) Superoxide scavenging effects of N-acetylcysteine and vitamin C in subjects with essential hypertension. Am. J. Hypertens. 18, 1111-1117
95. Virdis, A., Colucci, R., Fornai, M., Polini, A., Daghini, E., Duranti, E., Ghisu, N., Versari, D., Dardano, A., Blandizzi, C., Taddei, S. et al. (2009) Inducible nitric oxide synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats. Endocrinology 150, 1033-1042
96. + -coupled L-ascorbic acid (vitamin C) transporter SVCT1. Am. J. Physiol. Cell. Physiol. 294, C451-C459
97. Graumlich, J. F., Ludden, T. M., Conry-Cantilena, C., Cantilena, Jr, L. R., Wang, Y. and Levine, M. (1997) Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion. Pharm. Res. 14, 1133-1139
98. Jackson, T. S., Xu, A., Vita, J. A. and Keaney, Jr, J. F. (1998) Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ. Res. 83, 916-922
99. Duconge, J., Miranda-Massari, J. R., Gonzalez, M. J., Jackson, J. A., Warnock, W. and Riordan, N. H. (2008) Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate. P.R. Health. Sci. J. 27, 7-19
100. Padayatty, S. J., Sun, A. Y., Chen, Q., Espey, M. G., Drisko, J. and Levine, M. (2010) Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS ONE 5, e11414
101. Basili, S., Tanzilli, G., Mangieri, E., Raparelli, V., Di Santo, S., Pignatelli, P. and Violi, F. (2010) Intravenous ascorbic acid infusion improves myocardial perfusion grade during elective percutaneous coronary intervention: relationship with oxidative stress markers. JACC Cardiovasc. Interv. 3, 221-229
102. Yang, Z. and Ming, X. F. (2006) Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin. Med. Res. 4, 53-65
103. Carnes, C. A., Chung, M. K., Nakayama, T., Nakayama, H., Baliga, R. S., Piao, S., Kanderian, A., Pavia, S., Hamlin, R. L., McCarthy, P. M. et al. (2001) Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ. Res. 89, E32-E38
104. Eslami, M., Badkoubeh, R. S., Mousavi, M., Radmehr, H., Salehi, M., Tavakoli, N. and Avadi, M. R. (2007) Oral ascorbic acid in combination with β-blockers is more effective than β-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting. Texas Heart Inst. J. 34, 268-274
105. Papoulidis, P., Ananiadou, O., Chalvatzoulis, E., Ampatzidou, F., Koutsogiannidis, C., Karaiskos, T., Madesis, A. and Drossos, G. (2011) The role of ascorbic acid in the prevention of atrial fibrillation after elective on-pump myocardial revascularization surgery: a single-center experience - a pilot study. Interact. Cardiovasc. Thorac. Surg. 12, 121-124
106. Rasoli, S., Kourliouros, A., Harling, L. and Athanasiou, T. (2011) Does prophylactic therapy with antioxidant vitamins have an effect on atrial fibrillation following cardiac surgery? Interact. Cardiovasc. Thorac. Surg. 13, 82-85
107. Tsovolas, K., Iliodromitis, E. K., Andreadou, I., Zoga, A., Demopoulou, M., Iliodromitis, K. E., Manolaki, T., Markantonis, S. L. and Kremastinos, D. T. (2008) Acute administration of vitamin C abrogates protection from ischemic preconditioning in rabbits. Pharmacol. Res. 57, 283-289
108. Upston, J. M., Witting, P. K., Brown, A. J., Stocker, R. and Keaney, J. F. (2001) Effect of vitamin E on aortic lipid oxidation and intimal proliferation after arterial injury in cholesterol-fed rabbits. Free Radical Biol. Med. 31, 1245-1253
109. Terentis, A. C., Thomas, S. R., Burr, J. A., Liebler, D. C. and Stocker, R. (2002) Vitamin E oxidation in human atherosclerotic lesions. Circ. Res. 90, 333-339
110. Shi, H., Noguchi, N. and Niki, E. (1999) Comparative study on dynamics of antioxidative action of a-tocopheryl hydroquinone, ubiquinol, and a-tocopherol against lipid peroxidation. Free Radical Biol. Med. 27, 334-336
111. Gianello, R., Libinaki, R., Azzi, A., Gavin, P. D., Negis, Y., Zingg, J. M., Holt, P., Keah, H. H., Griffey, A., Smallridge, A. et al. (2005) α-Tocopheryl phosphate: a novel, natural form of vitamin E. Free Radical Biol. Med. 39, 970-976
112. Engelhart, K., Jentzsch, A. M., Fürst, P. and Biesalski, H. K. (1998) Short-term parenteral application of α-tocopherol leads to increased concentration in plasma and tissue of the rat. Free Radical Res. 29, 421-426
113. Rabl, H., Koschsorur, G. and Petek, W. (1995) Antioxidant vitamin treatment: effect on lipid peroxidation and limb swelling after revascularisation operations. World J. Surg. 19, 738-744
114. Rabl, H., Khoschsorur, G., Colombo, T., Petritsch, P., Rauchenwald, M., Költringer, P., Tatzber, F. and Esterbauer, H. (1993) A multivitamin infusion prevents lipid peroxidation and improves transplantation performance. Kidney Int. 43, 912-917
115. Bartels, M., Biesalski, H. K., Engelhart, K., Sendlhofer, G., Rehak, P. and Nagel, E. (2004) Pilot study on the effect of parenteral vitamin E on ischemia and reperfusion induced liver injury: a double blind, randomized, placebo-controlled trial. Clin. Nutr. 23, 1360-1370
116. Miller, III, E. R. Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J. and Guallar, E. (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 142, 37-46
117. De Tullio, M. C. (2012) Beyond the antioxidant: the double life of vitamin C. Subcell. Biochem. 56, 49-65
118. Ulker, S., McKeown, P. P. and Bayraktutan, U. (2003) Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 41, 534-539
119. 2 with anti-inflammatory activity. Mol. Cell. Biochem. 345, 69-76
120. Joensen, A. M., Overvad, K., Dethlefsen, C., Johnsen, S. P., Tjønneland, A., Rasmussen, L. H. and Schmidt, E. B. (2011) Marine n-3 polyunsaturated fatty acids in adipose tissue and the risk of acute coronary syndrome. Circulation 124, 1232-1238
121. Angerer, P. and von Schacky, C. (2000) n-3 Polyunsaturated fatty acids and the cardiovascular system. Curr. Opin. Clin. Nutr. Metab. Care 3, 439-445
122. Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P. et al. (2002) Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105, 1897-1903
123. 2+ dynamics and antioxidant status. Free Radical Biol. Med. 40, 1592-1602
124. Caló, L., Bianconi, L., Colivicchi, F., Lamberti, F., Loricchio, M. L., de Ruvo, E., Meo, A., Pandozi, C., Staibano, M. and Santini, M. (2005) n-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J. Am. Coll. Cardiol. 45, 1723-1728
125. Mariscalco, G. and Engström, K. G. (2009) Postoperative atrial fibrillation is associated with late mortality after coronary surgery, but not after valvular surgery. Ann. Thorac. Surg. 88, 1871-1876
126. Heidarsdottir, R., Arnar, D. O., Skuladottir, G. V., Torfason, B., Edvardsson, V., Gottskalksson, G., Palsson, R. and Indridason, O. S. (2010) Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery? Europace 12, 356-363
127. Saravanan, P., Bridgewater, B., West, A. L., O'Neill, S. C., Calder, P. C. and Davidson, N. C. (2010) Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. Circ. Arrhythm. Electrophysiol. 3, 46-53
128. Benedetto, U., Angeloni, E., Melina, G., Danesi, T. H., Di Bartolomeo, R., Lechiancole, A., Refice, S., Roscitano, A., Comito, C. and Sinatra, R. (2011) n-3 Polyunsaturated fatty acids for the prevention of postoperative atrial fibrillation: a meta-analysis of randomized controlled trials. J. Cardiovasc. Med., doi: 10.2459/JCM.0b013e32834a13c1
129. Rodrigo, R., Cereceda, M., Castillo, R., Asenjo, R., Zamorano, J., Araya, J., Castillo-Koch, R., Espinoza, J. and Larraín, E. (2008) Prevention of atrial fibrillation following cardiac surgery: basis for a novel therapeutic strategy based on non-hypoxic myocardial preconditioning. Pharmacol. Ther. 118, 104-127
130. Anderson, E. J., Thayne, K., Harris, M., Carraway, K. and Shaikh, S. R. (2012) Aldehyde stress and up-regulation of Nrf2-mediated antioxidant systems accompany functional adaptations in cardiac mitochondria from mice fed n-3 polyunsaturated fatty acids. Biochem. J. 441, 359-366
131. Castillo, R., Rodrigo, R., Perez, F., Cereceda, M., Asenjo, R., Zamorano, J., Navarrete, R., Villalabeitia, E., Sanz, J., Baeza, C. and Aguayo, R. (2011) Antioxidant therapy reduces oxidative and inflammatory tissue damage in patients subjected to cardiac surgery with extracorporeal circulation. Basic Clin. Pharmacol. Toxicol. 108, 256-262